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Abstract.  We have studied the posttranslational 
modifications of the 52-kD protein,  an estrogen- 
l~gulated autocrine mitogen secreted by several human 
breast cancer cells in culture (Westley,  B., and H. 
Rochefort,  1980, Cell,  20:353-362).  The secreted 
52-kD protein was found to be phosphorylated mostly 
(94%) on high-mannose  N-linked oligosaccharide 
chains,  and mannose-6-phosphate  signals were 
identified.  The phosphate signal was totally removed 
by alkaline phosphatase hydrolysis. The secreted 
52-kD protein was partly taken up by MCF7 cells via 
mannose-6-phosphate receptors and processed into 
48- and 34-kD protein moieties as with lysosomal 
hydrolases. By electron microscopy, immunoperoxidase 
staining  revealed most of the reactive proteins in lyso- 
somes. After complete purification by immunoaffinity 
chromatography,  we identified both the secreted 52-kD 
protein and its processed cellular forms as aspartic 
and acidic proteinases specifically inhibited by pep- 
statin.  The 52-kD protease is secreted in breast cancer 
cells under its inactive proenzyme form, which can be 
autoactivated at acidic pH with a  slight decrease of 
molecular mass.  The enzyme of breast cancer cells, 
when compared with cathepsin D(s) of normal tissue, 
was found to be similar in molecular weight,  en- 
zymatic activities (inhibitors,  substrates,  specific ac- 
tivities), and immunoreactivity.  However, the 52-kD 
protein and its cellular processed forms of breast can- 
cer cells were totally sensitive to endo-13-N-acetyl- 
glucosaminidase H  (Endo H), whereas several cellular 
cathepsin D(s) of normal tissue were partially Endo 
H-resistant.  This difference, in addition to others con- 
cerning tissue distribution,  mitogenic activity and hor- 
monal regulation,  strongly suggests that the 52-kD 
cathepsin D-like enzyme of breast cancer cells is 
different from previously described cathepsin D(s). 
The 52-kD estrogen-induced lysosomal proteinase may 
have important functions in facilitating the mammary 
cancer cells to proliferate, migrate,  and metastasize. 
T 
HE mechanism of the control of cell proliferation  by 
intraceUular hormones is unknown but can be studied 
in hormone-responsive human cell lines.  The recent 
discovery of a close relationship  between some oncogenes 
(Bishop,  1983) and growth factors (Waterfield,  1985), some 
of which act as autocrine signals (Sporn and Todaro,  1980; 
Heldin and Westermark,  1984), could serve as a guide in 
finding a new class of growth factors and oncogene products 
which  are  regulated  by  steroid  hormones  in  hormone- 
responsive cancer.  In the estrogen receptor-positive human 
breast cancer cells (Lippman et al., 1976; Soule et al., 1973), 
estrogens stimulate the synthesis of several secreted proteins 
(reviewed  in Rochefort et al.,  1986) and subsequently in- 
crease cell proliferation.  We have more specifically  studied 
a glycoprotein,  defined according  to its apparent molecular 
mass  in  SDS  PAGE (52,000  daltons,  52  kD),  which  is 
secreted into  the  culture  medium  when  MCF7  cells  are 
treated  with estrogens (Westley and Rochefort,  1980). The 
protein contains  at least two N-linked  high-marmose  or hy- 
brid oligosaccharide  chains  (Touitou  et al.,  1985) and  is 
processed intracellularly  into a 48-kD protein and a more 
stable 34-kD protein (Morisset et al., 1986a). The distribu- 
tion of this protein in human tissues,  as determined with 
several monoclonai antibodies  by using immunoperoxidase 
staining  (Garcia  et  al.,  1985),  appears  to  be  relatively 
specific  for epithelial  mammary  cells,  sweat  glands,  and 
liver, and to be associated with tumor development and/or 
cell growth. The protein has been detected in several human 
mammary cancers but not in the normal resting  mammary 
gland or in endometrium (Garcia et al., 1984). In a study of 
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staining  was found to be associated with cysts and ductal 
hyperplasias, both being lesions that increase the risk of de- 
veloping breast cancer (Garcia et al.,  1986). 
Several characteristics of the 52-kD protein suggest that 
it  might  be  an  autocrine  mitogen  (Vignon  et  al.,  1983; 
Rochefort et al.,  1984): (a) its increased level in the medium 
always precedes the stimulation of cell growth by estrogen; 
(b) the protein  is not secreted when the  wild-type MCF7 
cells are treated by antiestrogens or progestins that block cell 
growth; (c) the 52-kD protein became specifically inducible 
by antiestrogens  in  antiestrogen-resistant  clones of MCF7 
cells, unlike other regulated proteins (Westley et al.,  1984); 
(d)  more directly,  the purified  52-kD protein  (Capony et 
al.,  1986) stimulated the growth of resting MCF7 cells and 
transformed the cell surface (Vignon et al.,  1986). 
In an attempt to identify the function ~tf this protein,  we 
have studied its posttranslational modifications and searched 
for an enzymatic activity. In a preliminary report, we noticed 
that the secreted 52-kD protein contains mannose-6-phos- 
phate signals and displays an in vitro acidic proteinase activ- 
ity (Morisset et al., 1986b). We now report a complete char- 
acterization  of the  posttranslational  modifications  of the 
secreted and cellular 52-kD protein, and of its cellular local- 
ization and processing. The enzymatic activities of the cellu- 
lar and secreted 52-kD proteins have been characterized and 
compared to normal human cathepsin D(s). 
Materials and Methods 
Cell Culture 
MCF7 cells were derived from a metastatic human breast cancer and sup- 
plied by the Michigan Cancer Foundation (Detroit). Cells plated out in wells 
(Nunc 3.5-cm diam) at a  concentration of 3  x  105 cells per well were 
hormone-withdrawn for 6 d, and then stimulated with estradiol (10 nM) for 
2 d as previously described (Westley  and Rochefort, 1980). 
Labeling of  Cells 
After stimulation, the cells were labeled with [35S]methionine  (200 gCi/ 
ml)  for 8  h  in  500  gl  of MEM  as previously described (Westley and 
Rochefort, 1980).  To label glycoproteins, cells were labeled in 500 gl of 
MEM containing 1/10th the normal concentration of glucose plus 0.6 mCi/ 
ml  of  [2-33H]mannose  (54  Ci/mmol,  Amersham International,  Amer- 
sham, UK) or D-[U-14C]glucose (0.3 Ci/mmol, Commissariat ~t l'Energie 
Atomique,  Saclay,  France).  For  32p-labeling,  the cells were first rinsed 
twice with 1 ml of MEM containing 1/20th  the normal concentration of 
phosphate and labeled for 7 h in 500 Ixl of the same MEM plus 2 mCi/ml 
of [32p]H3PO4 (Commissariat ~t l'Energie Atomique). At the end of the in- 
cubation, NaF was added to the 32p-labeled medium at a final concentra- 
tion of 10 raM, and the cells were rinsed twice in cold PBS containing 10 
mM NaF. 
Preparation of  Medium, NP40 Cell Extracts, and 
Immunoprecipitation of the Secreted and Cellular 
52-kD Proteins 
After labeling,  the media were collected and  centrifuged for 5  rain at 
1,200 g. The cells were lysed directly in the wells in 10 mM Na H2PO4, 
pH  7.4,  10  mM  NaC1,  10  mM  EDTA,  1%  NP-40  (wt/voi),  1  mM 
phenylmethylsnifonyi fluoride (PMSF), and 100 kalikrein inhibitors units 
of trasyloi (Sigma Chemical Co.) per ml and centrifuged to give a NP-40 
cell lysate. Immunoprecipitation of  the cellular 52-kD proteins were carded 
out in 100 mM Na H2PO4, pH 7.4, 2% BSA, 1% NP-40, 1% sodium deox- 
ycholate, 0.1%  SDS with hybridoma supernatant containing 10  gg/ml of 
M1G8 monoclonal antibody to the 52-kD protein and 5 % of normal BALB/c 
mouse serum (Garcia et al., 1984). After 18 h at room temperature, sheep 
anti-mouse antibody was added and the incubation continued for 22 h. Im- 
munoprecipitates were pelleted in an Eppendorf  microfuge (Hamburg, Fed- 
eral Republic of Germany) and washed three times in immunoprecipitation 
buffer but with 1 mM EDTA and without BSA. Control immunoprecipita- 
tions were carried out with a supernatant of  parental myeloma strain. Deter- 
gents were omitted to immunopreeipitate the secreted 52-kD protein. 
Purification of  the Secreted and Cellular 
52-kD Proteins 
Proteins were purified by sequential column chromatographies on con- 
canavalin A (Con A)-Sepharose and anti-52-kD antibody-Sepharose as de- 
scribed (Vignon et al., 1986; Capony et al., 1986). Elution from the immu- 
noaflinity column was performed either at pH 3.0 or 11.0 as indicated when 
necessary. 
Detection of  Phosphoamino Acids in Protein 
The secreted 52-kD protein was immunoprecipitated and subjected to SDS 
PAGE. Radioactive bands detected by autoradiography corresponding to the 
52-kD proteins were cut out and processed as described by Cooper et al. 
(1983)  for hydrolysis and purification on Dowex AG1-X8 (Dow Coming 
Corp., Midland, MI). Separation of phosphoamino acids was carded out 
by cation exchange as previously described (Capony and Demaille, 1983). 
Detection of  Phosphorylated Oligosaccharides 
The radioactive secreted or cellular 52-kD immunoprecipitates were dis- 
solved in 50 mM NaH2PO4, pH 5.4, containing 1% SDS heated for 1 rain 
at 100°C, and diluted 10-fold with quartz double-distilled water to dilute the 
SDS to 0.1%.  Endo-I~-N-acetylglucosaminidase H (Endo H), 1 from Miles 
Laboratories, Inc. (Elkhart, IN) was added at I>25 mU/ml and the samples 
were incubated for 16-18 h at 37°C. The proteins were then precipitated with 
10% TCA, and the precipitates were analyzed by SDS PAGE. 
The TCA-soluble oligosaceharides were neutralized with 5 N NaOH and 
the free radioactive label ([32p]_ or [3H]marmose)  was eliminated by gel 
filtration on Sephadex 1325 (PD10 column, Pharmacia Fine Chemical, Upp- 
sala, Sweden) in 0.1 M pyridine-acetic acid, pH 5.0. Samples were then sub- 
jected to high-voltage paper electrophoresis for 15-20 rain at 40 V/cm in 
a Desaga Desaphor electrophorator (Heidelberg, Federal Republic of Ger- 
many) on Whatman 3MM paper (Whatman, Inc., Clifton, NJ) saturated 
with 30 mM NI-I4H CO3 (Sahagian and Gottesman,  1982).  The electro- 
pherograms were exposed to X.Omat S films to detect 32p or cut into 1-cm 
strips for 3H-radioactivity counting. 
Sugar Analysis 
Endo  H-released oligosaccharides labeled  with  D-[U-~C]glucose were 
hydrolyzed with 1 N HCI at 100°C for 2 h. The carbohydrates were then 
analyzed by descending chromatography for 22 h on Whatman 3MM paper 
in N-butanol/pyridine/O.1  N  HC1  (5:3:2).  Radioactivity was counted as 
above for 3H and sugar standards (Sigma Chemical Co., St.  Louis, MO) 
were detected with aniline oxalate (Broquet et al.,  1982). 
Identification of  Mannose-6-phosphate 
The oligosaccharides were lyophylized and hydrolyzed in 2  M  trifluoro- 
acetic acid (TFA)  in sealed tubes for 2 h at  110  ° as described elsewhere 
(Sahagian and Gottesman, 1982). The acid hydrolysates were then dried un- 
der nitrogen to eliminate TFA, and the residues were dissolved in 5 mM 
Tris-HC1, pH 9.0. Aliquots were counted for radioactivity and samples were 
submitted to high-voltage paper electrophoresis as above.  Authentic man- 
nose-6-phosphate was run as external and internal controls (20-50 I.tg) and 
revealed by the ammoniaeal silver stain reagent (Trevelyan  et al.,  1950). 
Portions  of  N-glycosylated  chains  or  acid  hydrolysates  containing 
200-500 cpm 32p were treated for 2 h at 37°C with or without 0.12 U of 
Escherichia coli alkaline phosphatase (Sigma Chemical Co., type II N) in 
20 I~l of Tris buffer,  pH 9.0. The alkaline phosphatase activity was tested 
in parallel on 50 gg of authentic mannose-6-phosphate. 
QAE-Sephadex Fractionation and Mild Acid Hydrolysis 
Endo H-released oligosaccharides were first separated from the polypep- 
tides by chromatography on a Biogel P30 column (Bio-Rad Laboratories, 
1. Abbreviations used in this paper: Endo H, endo-13-N-acetylglucosamini- 
dase H; TFA, trifluoroacetic acid. 
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the secreted and cellular 52- 
kD  proteins  in  MCF7 cells. 
Estrogen-treated  MCF7  cells 
were labeled with either [3~S]- 
methionine or [32p]H3PO4 as 
indicated. Media and cell ex- 
tracts  were  immunoprecipi- 
tated with the M1G8 antibody 
to the 52-kD protein and ana- 
lyzed by  SDS  PAGE  as  de- 
scribed  in  Materials  and 
Methods. (A) Proteins of me- 
dia  (M)  (lanes a  and  c)  and 
cell extracts (C) (lanes e  and 
g), labeled by 3ss and 32p and 
analyzed  before  (M,  C)  and 
after  (Igl)  immunoprecipita- 
tion with the anti-52-kD pro- 
tein  antibody  (lanes  b,  d,  f, 
and h).  (B) The immunopre- 
cipitated 52-kD proteins were 
digested (+) or not (-)  with 
Endo H  and the TCA-precipi- 
tated  proteins  were  electro- 
phoresed and revealed by au- 
toradiography  (32p)  or  silver 
stained. Lanes a and b: secret- 
ed 52-kD protein. Lanes c-f: 
cellular related proteins.  The 
three  immunoreactive  pro- 
teins are arrowed. 
Richmond, CA) (1  x  1(30 cm) in 1 M pyridine acetic  acid, pH 5.0, 0.2% 
SDS. QAE-sephadex  chromatography  and mild acid hydrolysis  were then 
performed as described by Tabas and Kornfeld  (1980). 
Ultrastructural Localization by 
Immunoperoxidase Staining 
MCF7  cells stimulated  by estradiol (10 nM)  for 3  d  were fixed  in 3% 
paraformaldehyde  and 0.05%  glutaraldehyde  and treated for 30 min with 
PBS containing 0.05 % saponin for membrane permeation. Indirect immu- 
noperoxidase  staining was performed as described elsewhere (Garcia et al., 
1984). Enzyme activity was revealed using diaminobenzidine (Graham and 
Karnovsky, 1966). After 1 h of postfixation with osmium tetroxide (1.33 %) 
in collidine buffer, cells were embedded in Epon. The sections were stained 
with uranyl acetate and examined with a Philips EM 301 microscope (Eind- 
hoven, The Netherlands) at 60 kV. 
Proteolytic Activity Assays 
Both the secreted and cellular 52-kD related proteins were purified.  The fi- 
nal elution was either with citrate buffer, pH 3, followed by dialysis in a 50 
mM acetate buffer, pH 5, with 0.0025 % Tween 80 (E.  Merck, Darmstadt, 
Federal Republic of Germany) or with lysine buffer, pH U, without dialysis. 
The reaction mixture contained routinely 10,000 cpm of [14C]methemoglo- 
bin (New England Nuclear,  Boston, MA), 100 I.tg of unlabeled methemo- 
globin, 10-90 ng of purified enzyme, and reaction buffer at appropriate pH 
in a final volume of 100 ~tl. The reaction was initiated by the addition of 
the enzyme and terminated by adding "IUA (final concentration 10%). TCA- 
soluble material in 25-~tl aliquots was counted for radioactivity.  Blanks run 
with dialysis  buffer in place of the enzyme were subtracted.  At 37°C, the 
reaction was linear up to 15 min (purification  at pH 3) or 60 min (purifica- 
tion at pH  U), and incubation times of 10 min and 30 min were chosen, 
respectively. 
Double-labeled proteoglycans  (kindly given by Dr. Mitrovic,  INSERM 
U18, H6pital Lariboisi~re,  Paris) were also tested as substrate.  Briefly, hu- 
man chondrocyte  proteoglycans  were labeled in culture with [3H]glycine 
and 3sSO4, and purified as described (Mitrovic et al., 1981). 20,000 cpm of 
35SO4 and 87,000 cpm of 3H-labeled proteoglycans  were digested by 80 ng 
of purified secreted 52-kD protein at different pH in 110 ltl of buffer for 45 
min at 370C. After TCA precipitation (10% final) in the presence of 25% 
FCS,  the TCA-soluble material was decanted and counted for 3H and 3sS 
radioactivity  using a double-channel program. 
Bovine spleen cathepsin D (EC 3.4.23.5) was from Sigma Chemical Co., 
the human liver  cathepsin D (form 34 kD) was prepared according to Barrett 
(1970). The sheep antiserum to human cathepsin D (SA237) was prepared 
as described by Dingle et al.  (1971). 
Other Methods 
SDS PAGE was performed by the method of Laemmii (1970) with a  15 % 
acrylamide  gel.  Samples  were  prepared  as  described  by  Westley  and 
Rocbefort (1980). Gels containing 3H and 3sS material were processed for 
fluorography;  those containing 32p were autoradiographed.  Unlabeled pro- 
teins were  stained  with the Bio-Rad  Laboratories  silver-stain  kit.  The 
molecular mass of proteins was estimated by their mobilities relative  to 
molecular mass protein standards  for SDS PAGE (Bio-Rad Laboratories). 
Radioactive samples were counted in 4 ml of scintillator emulsifier 299 
(United Technologies,  Packard Instrument Co., Inc., Zurich, Switzerland) 
in an SL30 Intertechnique liquid scintillation spectrometer (Intertechnique, 
Plaisir,  France). 
Results 
Biosynthetic Phosphorylation on 
N-glycosylated Chains 
When  confluent  MCF7  cells grown in the presence of es- 
tradiol were exposed to [32p]HaPO4  for 7  h,  in a  serum-free 
medium, several phosphorylated proteins were released into 
the  culture medium.  A  protein with  a  molecular mass  of 
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Figure 2.  Higla-voltage  paper  electrophoresis  of (A)  [2-3H]man - 
nose- or (B) 32p-labeled oligosaccharides.  The secreted 52-kD 
protein was immunoprecipitated and digested with Endo H. The 
cleaved oligosaccharide chains were analyzed before and after hy- 
drolysis  with TFA by high-voltage paper electrophoresis  with 
authentic mannose-6-phosphate (M6P), [3H]mannose (Man), and 
[32p]H3PO  4 (321)). (A) [3H]mannose  labeling. (Panel a) intact N-gly- 
cosylated chains; (panel b) TFA hydrolyzed sugars. Radioactivity 
was  detected as described  in  Materials and  Methods.  (B) 32p_ 
labeling. Intact N-glycosylated chains (panels a and b) and TFA- 
hydrolyzed sugars (panels c and d) were digested with alkaline 
phosphatase (panels b-d)  or not digested (panels a-c)  before analy- 
sis. The 32p-labeled material was autoradiographed and scanned 
using a Vernon scanning densitometer. 
52,0(0) daltons was one of the most phosphorylated proteins. 
It was identified as the estrogen-regulated 52-kD protein by 
specific immunoprecipitation (Fig. 1 A, lanes c and d). The 
52-kD  protein  immunoprecipitated  after  [35S]methionine 
labeling was analyzed in parallel (Fig.  1 A, lanes a  and b). 
No other proteins were recognized by the monoclonal anti- 
bodies. Cells deprived of estrogens do not secrete the 52-kD 
protein and therefore no 32p_ or 35S-labeled 52-kD proteins 
were observed in the medium (results not shown). The cell 
extract was analyzed similarly. After [35S]methionine  label- 
ing, three bands migrating as proteins with molecular mass 
of 52,000, 48,0(0), and 34,000 daltons were immunoprecipi- 
tated (Fig.  1 A, lanes e and f). The 48- and 34-kD proteins 
are processed products of the 52-kD protein as shown by 
pulse-chase experiments (Morisset et al., 1986a). The 34-kD 
protein is the most abundant and stable of these three pro- 
teins. The immunoreactive cellular proteins were labeled by 
32p mostly on the 52- and 48-kD forms (Fig.  1 A, lanes g and 
h). The 34-kD protein was labeled weakly by [35S]methio- 
nine and very weakly by 32p (not detected in Fig.  1 A). 
We conclude that the 52-kD protein is phosphorylated in 
vivo in the cellular compartment and remains phosphory- 
lated when secreted into the medium under estrogen stimu- 
lation. 
The phosphorylation site(s) of the secreted purified 52-kD 
protein labeled biosynthetically by [32p]H3PO4,  was  (were) 
then  identified.  After  acid  hydrolysis  of peptide  honds 
(Cooper et al.,  1983),  the phosphoamino acids were sepa- 
rated on an amino acid analyzer and revealed by autoradiog- 
raphy (Capony and DemaiUe, 1983). Only 3%-5% of the to- 
32p radioactivity hound to the protein was recovered. It 
migrated mostly with serine (90%) and to a lesser extent with 
threonine (9%), and tyrosine was hardly detectable. Because 
the proportion of 32p incorporated into the 52-kD glycopro- 
tein and recovered into amino acids was low, we suspected 
that the oligosaccharide moiety was also phosphorylated. In 
fact, treatment by Endo H, which removes the two N-glyco- 
sylated chains of the secreted 52-kD protein and displaces 
the 35S-labeled protein to lower molecular mass of 50- and 
48-kD (Touitou et al.,  1985),  also removed 94% of the 32p 
from the 52-kD protein (Fig. 1 B, lanes a and b). This indi- 
cated that the majority of the 32p label of the 52-kD protein 
was  incorporated  into  the  high-mannose  N-glycosylated 
chains.  Endo H  had the same effect on the three immuno- 
related  cellular proteins  (Fig.  1 B,  lanes  c-f).  This  was 
confirmed  by  analyzing  the  32p  or  [3H]mannose-labeled 
N-glycosylated chains released by Endo H treatment. When 
the N-glycosylated chains of the secreted 52-kD protein were 
labeled by  [3H]mannose  and  analyzed at  pH  8  by  high- 
voltage paper electrophoresis, half of them migrated as an 
acidic component and half as a neutral component (Fig. 2 A, 
panel a). When labeled by [32p]H3PO4 (Fig. 2 B, panel a), 
the cleaved oligosaccharide chains migrated as the acidic 
compound labeled with [3H]mannose. The bulk of the 32p 
was removed by alkaline phosphatase and migrated as free 
H3PO4, indicating that most of the phosphate was linl~ed to 
the N-glycosylated chain by a monoester bond and not pro- 
tected by a terminal sugar (Fig. 2 B, panel b). 
Mannose-6-phosphate Signal and 
Lysosomal Localization 
The [3H]mannose- or [32p]H3PO4-1abeled oligosaccharides 
were hydrolyzed with TFA, and the monosaccharides were 
electrophoresed on paper.  20%  of the incorporated 3H ra- 
dioactivity migrated with the mobility of authentic mannose- 
6-phosphate run in parallel (Fig. 2 A, panel b), while most 
of the 3H radioactivity migrated as  [3H]mannose. The 32p 
incorporated into monosaccharides  migrated  as  authentic 
mannose-6-phosphate. It was totally liberated as free [32p]_ 
phosphate after alkaline phosphatase treatment (Fig.  2  B, 
panels c and d). 
The N-glycosylated chains  of the three immunopurified 
cellular-related 52-kD  proteins are also Endo H-sensitive 
and most of their phosphorylation is removed by this en- 
zymatic digestion (Fig. 1 B). After biosynthetic labeling by 
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nose 6-phosphate of the up- 
take and processing of the 52- 
kD  protein by  MCF7 cells. 
Confluent MCF7 cells  (1  × 
106 cells) maintained in FI2/ 
DME  containing  1%  FCS/ 
dextran-coated charcoal were 
rinsed twice in FI2/DME plus 
0.1% BSA. They were then in- 
cubated with 400 ttl of con- 
ditioned  media  containing 
[35S]methionine-labeled pro- 
teins secreted by MCF7 cells 
(300,000  TCA-precipitable 
counts) for 24 h in F12/DME 
with  (lane a)  0.1% BSA  alone (0),  or  (lane b)  10  mM man- 
nose-6-phosphate (M6P), or (lane c) 10 mM glucose-6-phosphate 
(G6P), or (lane d) 10 mM mannose-l-phosphate (MIP), or (lane 
e)  10 mM mannose (Man). The labeled ceils were then washed 
three times in F12/DME  plus 0.1% BSA, and the cell lysate proteins 
were immunoprecipitated  with the M1G8 anti-52-kD monoclonal 
antibody. The immunoprecipitates  of each series were analyzed by 
SDS PAGE and revealed by fluorography. 
[3H]mannose  and by [32p]H3PO4, the N-glycosylated chains 
recovered after Endo H digestion showed both neutral and 
acidic components in electrophoresis.  A  32p-labeled com- 
pound  migrating  as  mannose-6-phosphate  was  recovered 
after acid hydrolysis. However,  alkaline phosphatase only 
partially removed the 32p incorporated  into the cellular N-gly- 
cosylated chains,  suggesting  that  some  phosphomannose 
residues were covered. The behavior of the cellular 52-kD 
oligosaccharide chains on the QAE-Sephadex column was 
studied according to Tahas and Kornfeld (1980). Five peaks 
were eluted by increasing concentrations of NaC1 from O to 
100 mM indicating a large heterogeneity of these N-glyco- 
sylated chains (not shown). Approximately 20%  were neu- 
tral  whereas  the  rest  had  a  variable  number  of negative 
charges. 80% of the two major peaks (30%  each) eluted at 
70 and 100 mM were sensitive to alkaline phosphatase, sug- 
gesting that they contained accessible mannose-6-phosphate. 
Sugar analysis after total acid hydrolysis of the secreted and 
cellular oligosaccharide chains biosynthetically  labeled with 
I)-[U-~4C]glucose revealed mannose and N-acetylglucosamine 
in an approximate molar ratio of 5:2. No other radiolabeled 
sugars could be detected. 
The presence of mannose-6-phosphate signals on the se- 
creted 52-kD protein was also indirectly demonstrated by in- 
cubating the 35S-labeled secreted proteins containing 1 nM 
concentration  of 52-kD  protein  with  unlabeled  recipient 
MCF7  cells as described by Vignon et al.  (1986). Under 
these conditions, 4% of the 52-kD protein was taken up and 
processed into 34-kD protein (Fig. 3, lane a). When man- 
nose-6-phosphate was added as a competitor to the labeled 
incubation medium, the  uptake  and processing  of 35S-la- 
beled 52-kD protein was negligible (Fig. 3, lane b). In con- 
trast, incubation with glucose 6-phosphate, mannose 1-phos- 
phate, or mannose did not prevent the uptake and processing 
into a 34-kD protein (Fig. 3, lanes c-e). This result indicates 
that the breast cancer cells have mannose-6-phosphate recep- 
tors located on their plasma membrane, and that these recep- 
tors facilitate the cellular binding and uptake of the 52-kD 
protein, as described for other lysosomal enzymes (Creek 
and Sly, 1984). After incubation, the 52-kD protein remain- 
ing in the medium was not processed into the 48- and 34-kD 
forms,  suggesting that the enzyme(s) responsible  for this 
processing is (are)  intracellular. 
We then used an anti-52-kD monoclonal antibody, which 
also  recognizes the processed  cellular  34-kD  protein,  to 
localize these proteins in MCF7 cells, using indirect immu- 
noperoxidase  staining  and  electron-microscopic  analysis 
(Fig.  4).  The  immunoreactive proteins  were  exclusively 
found in the cytoplasm and mostly concentrated in multi- 
vesicular bodies and lysosomal vesicles, identified as lyso- 
somes by acid phosphatase activity. Most of the lysosomes 
containing these proteins were located close to mitochondria 
and microfilaments. By contrast, only weak staining was ob- 
served in Golgi complexes, and no staining was observed 
with control monoclonal IgG1 mouse antibody (not shown). 
The ultrastructural localization of the protein was in total 
agreement with the biochemical characterization of man- 
nose-6-phosphate signals and indicated that the 52-kD pro- 
tein is the precursor of a lysosomal protein, partly secreted 
after  estrogen  stimulation and  targeted  to  lysosomes via 
mannose-6-phosphate receptors. 
Aspartic Proteinase Activity of the Secreted and 
Cellular Forms of the 52-kD Protein 
Our first unsuccessful attempts to find an enzymatic activity 
of the purified secreted 52-kD protein at neutral pH (our un- 
published results) were markedly reoriented on the basis of 
its lysosomal localization. When the secreted 52-kD protein 
and the related cellular proteins (52, 48, 34, and 17-kD) were 
purified to apparent homogeneity by Con A-Sepharose chro- 
matography  followed  by  immunoaflinity chromatography 
(Vignon et al., 1986; Capony et al., 1986), they displayed a 
strong proteolytic activity on [t4C]methemoglobin, with a 
maximum at pH 3.5 (Fig. 5 a). The substrate was degraded 
into small peptides, indicating that the enzyme was an endo- 
peptidase. The optimal pH was, however,  found to vary ac- 
cording to the substrate tested. For instance, when double- 
labeled ([3H]glycine and 35SO4) human proteoglycans were 
used as substrates instead of methemoglobin, the purified 
secreted 52-kD protein displayed a maximal activity at pH 
5.5 and was slightly active at pH higher than 6, suggesting 
that this secreted protease may act extracellularly in vivo 
(Fig. 5 a). 
Casein, albumin, and basement membranes were also sub- 
strates  for  this  protease  (Morisset,  unpublished  experi- 
ments). The initial rate of the reaction was dependent on the 
amount of  the secreted and cellular 52-kD protein, with a lin- 
ear relationship from 20 to 90 ng of protein (Fig. 5 b). The 
specific activity of the secreted 52 kD protein was identical 
to that of  the related cellular proteins consisting mostly of  the 
34- and 17-kD enzyme. Pepstatin was the most effective in- 
hibitor, leupeptin and EDTA had some activity at high con- 
centrations, and PMSF was inactive (Fig. 5 c). These results 
indicate that this proteinase is an aspartic proteinase similar 
to the previously described cathepsin D (Barrett, 1977). The 
proteinase activity is intrinsic to the 52-kD and related cellu- 
lar  proteins  in  that  its  specific  activity progressively  in- 
creased up to 200-fold during purification (Table I). The fi- 
nal specific activity (300-360 cpm solubilized per nanograrn 
of protein in 30 min) was similar whether the protein had 
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Total 
Total  enzyme  Specific  Purifi- 
Step  protein  activity  activity  Yield  cation 
/gg 
1.  Start medium  6,220 
2.  Con A  eluate  258 
3.  Ig G eluate  5 
cpm per ng 
cpm  x  10  -6  protein  %  -fold 
9.6  1.5  100  1 
6.6  26.4  69  17 
1.6  318  16.6  208 
The secreted 52 K protein was purified from 80 ml of culture medium condi- 
tioned by MCF~ ceils cultured with 10%  FCS, as described in Materials and 
Methods. The final elution of the immunoaflinity column (IgG) was at pH 11. 
Protein concentrations in the medium and the Con A eluate were determined 
by the Bradford technique and by scanning the traces of the silver-stained gel 
in the IgG eluate. Proteinase activity was assayed as described in Materials and 
Methods and expressed in counts per minute of [a4C]methemoglobin solubi- 
lized at pH 4.0 for 30 min. 
been eluted at acidic or alkaline pH. The purity of the final 
preparation used for enzymatic studies was shown by finding 
single  silver-stained  bands  of overloaded  SDS  polyacryl- 
amide gel (Capony et al.,  1986; Morisset et al.,  1986b) and 
Figure 4. Cellular localization of the 52-kD 
protein. MCF7 ceils cultured with estradiol 
were  fixed,  permeabilized,  and  incubated 
with the D7E3 anti-52-kD monoclonal anti- 
body (10 l~g/ml). They were immunostalned 
using  the  indirect  peroxidase-antiperoxi- 
dase technique  as  described  in  Materials 
and Methods. Staining was mostly observed 
in lysosomes. (Ly) lysosomes; (N) nucleus; 
(M)  mitochondria;  (mi) microfilaments. 
Bars,  1 lain. 
a  single  NH2-terminal  amino  acid  (Leu)  of the  purified 
secreted 52-kD protein (Ferrara et al., unpublished results). 
When the conditioned medium was passed through an im- 
munoaflinity column to remove the 52-kD protein, 96% of 
the proteolytic activity was retained on the column and re- 
covered after elution of the 52-kD protein. 
The first enzymatic assays were performed with a 52-kD 
secreted proteinase purified under conditions  (final elution 
step at pH  3.0)  which  could  autoactivate an  inactive pro- 
enzyme. To see whether the precursor 52-kD protein was se- 
creted in an active or inactive form, we then purified it with 
a final elution step at pH 11 and tested its proteolytic activity 
at pH 4.0.  The enzymatic activity was very low in the first 
8 min of incubation at pH 4.0, and increased thereafter (Fig. 
6  a).  The molecular weight of the secreted 52-kD protein 
(Fig.  6  a,  inset 1)  was slightly decreased to 51  kD under 
these conditions  (inset 2),  but  no 48- and 34-kD proteins 
were formed. The activation into the 51-kD protein was in- 
hibited by pepstatin (inset 3), indicating that the inactive 52- 
kD precursor undergoes an acid-dependent autoactivation, 
probably by removal of a  short propeptide at the NH2-ter- 
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Figure 5. Proteolytic activity of the secreted and cellular related 52- 
kD proteins  and of cathepsin D.  Proteolytic activities  of purified 
52-kD proteins and bovine cathepsin D (see Fig. 6 A) were assayed 
as described  in Materials  and Methods  (10 min at  37°C)  using 
10,000 cpm  of [14C]methemoglobin  (Met Hb)  or  3H-  and  35S- 
labeled  proteoglycans (PGs) as substrates.  TCA-solubilized  mate- 
rial was directly counted for radioactivity.  Three enzyme prepara- 
tions were used:  secreted  52-kD protein (open circles), cellular 
related protein (34 K) (closed circles) and bovine cathepsin D (open 
triangles). (a) Effect of pH. The reaction buffers are citrate buffer 
(pH 2.5--4.5),  acetate buffer (pH 5-6.5), phosphate buffer (pn 7.2), 
and Tris buffer (pH 8.4). 90 ng of each enzyme was used. (b) Effect 
of enzyme concentration.  Stock solutions  (pH  5.0) of cellular- 
related  52-kD protein containing mostly the 34-kD protein,  se- 
creted 52-kD and bovine cathepsin D were diluted in a pH 5.0 ace- 
tate buffer and finally assayed for proteolytic activities at a final pH 
of 4.0. (c) Effect of proteinase  inhibitors.  The proteolytic activity 
of 80 ng of purified cellular related 52-kD proteins  was assayed at 
pH 4.0 without and with increasing  concentrations of the indicated 
inhibitors.  The 100% value corresponded to the noninhibited  pro- 
teolysis  (4,000 cpm released  in 10 min). 
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Figure 6. Time-dependent acid activation of proteinase  activity. (a) 
The  secreted  and cellular  related  52-kD proteins  were purified 
(final elution at pH 11). 80 ng of each was then incubated  at pH 4.0 
with [aC]methemoglobin as substrate.  The reaction was stopped 
by adding TCA at the indicated  times.  80-ng samples  of purified 
secreted  52-kD protein were incubated  for 30 min at 37°C either 
at pH U.0 (1), or at pH 3.0 without (2) or with 1 IJ.M (3) pepstatin. 
They were then compared on an SDS polyacrylamide gel and silver 
stained.  (b) Conditioned media from MCF7 cells  treated  for 4 d 
with  estradiol  (E2CM) (solid symbols) or without estradiol  (C- 
CM) (empty symbols) were prepared as described (Vignon et al., 
1983).  They contained proteins released  for the last  18 h  under 
serum-free conditions in Ham's FI2-DME medium. Protein con- 
centration was made equal  in Ea-CM and C-CM (105 ltg per 700 
gl of final volume) by adding Ham's F12-DME medium. Proteinase 
activity was assayed by adding at time 0 the substrate mixture con- 
taining  70,000 cpm of [~C]methemoglobin, 700 I~g of unlabeled 
methemoglobin in citrate buffer (final pH 4.0).  100-gl aliquots were 
taken  from the same batches  at different times of incubation and 
proteolysis was stopped by adding TCA. 30-min samples were also 
assayed with 10 nM pepstatin  (triangles). 
minal  moiety of the  molecule.  Similar  autoactivation  has 
been described for cathepsin D of human fibroblasts (Hasilik 
et al.,  1982) and of bovine spleen (Puizdar and Turk,  1981). 
By  contrast,  both  the  secreted  precursor  prepared  under 
acidic conditions and the related cellular 52-kD proteins dis- 
played no lag in enzymatic activity (Fig. 6 a) and no change 
in their molecular mass, suggesting that they are fully active 
in acidic cellular organelles (endosomes, lysosomes). A sim- 
ilar time-dependent activation of the secreted proteinase was 
observed at acidic pH in the conditioned media containing 
proteins released by estradiol-treated  MCF7 cells,  and was 
also observed but at a much lower level in conditioned media 
from control MCF7 cells  (Fig.  6  b).  Inhibition of the pro- 
teolytic activity by pepstatin suggests that this activity is due 
to the 52-kD protein.  This result  indicates that the 52-kD 
protein is active before any purification and that MCF7 cells 
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cathepsin D. (A) Purity of the enzymes. (a) The secreted and the 
(b) cellular related 52-kD proteins were purified by two chromatog- 
raphy steps with final elution at pH 3.0 (Capony et al., 1986). 200 
ng of each preparation and (c) of bovine spleen cathepsin D were 
subjected to SDS PAGE  and silver stained. (B) Immunoreactivities. 
(Lanes a-c) Immunoprecipitation of the secreted and cellular 52- 
kD protein by antibodies to human liver cathepsin D. Media (M) 
and cell extracts (C) were prepared from MCF7 cells labeled with 
[3~S]methionine and incubated with an antiserum anti-human liver 
cathepsin D (Dingle et al., 1971) (lanes a and b, lgi) or an unrelated 
antiserum (lane c, Ign). The immunoprecipitates were isolated by 
protein-A Sepharose as described (Capony et al., 1982), analyzed 
by SDS PAGE and revealed by fluorography. (Lanes d-f)  Elec- 
trophoretic transfer and immunologic detection of 400 ng each of 
purified cathepsin D (Cat D) and cellular related 52-kD proteins 
(C) were performed with the M1G8 monoclonal antibody to the 
52 kD protein (IgO or an unrelated mouse antibody (Ign), as de- 
scribed (Garcia et al.,  1985). 
secrete little if any proteinase inhibitor(s) for this enzyme. 
Moreover, it shows that the 52-kD protein secreted by human 
breast cancer cells can act in vitro as a proteinase after its 
autoactivation at acidic pH, but without being processed into 
its smaller molecular forms generally present in lysosomes. 
Comparison with Cathepsin D from Normal Tissues 
We found similarities, but also differences, between the 52- 
kD  protein of MCF7  cells and  other cathepsin D(s)  from 
bovine and normal human tissues. The specific activity of  the 
secreted and related cellular 52-kD proteins were in the same 
range (55 %-80 %) as that of cathepsin D, as evaluated on the 
same substrate under zero-order kinetics (Fig. 5, a and b; Ta- 
ble I). The molecular mass of  the secreted 52-kD protein and 
of its cellular forms was similar to those of bovine liver (Fig. 
7 A) and human fibroblast cathepsin D (Gieselmann et al., 
1985). These cathepsin D(s), like the mammary 52-kD pro- 
tein, are processed into active lysosomal 48-kD and 34-kD 
17-kD proteinases. 
Moreover, polyclonal antibodies to human liver cathepsin 
D (Dingle et al.,  1971) specifically immunoprecipitated the 
35S-labeled secreted 52-kD protein and the related cellular 
proteins of MCF7 cells (Fig.  7 B, lanes a-c).  In addition, 
human 34-kD cathepsin D was detected by Western immuno- 
blot using the M1G8 monoclonal antibody to the 52-kD pro- 
tein (Fig. 7 B, lanes d-f).  Bovine cathepsin D was not de- 
tected by our antibodies, confirming their specificity for the 
human species (Garcia et al., 1985). These results show that 
the 52-kD-related proteins are antigenically closely related 
to cathepsin D and very similar to this proteinase. The amino 
acid  composition  of the  purified  52-kD  secreted  protein 
(Capony et al.,  1986) and human liver cathepsin D (Barrett, 
1977) were found to be similar. 
Moreover, the cathepsin  D-like enzyme of MCF7  cells 
has several characteristics that have not been previously de- 
scribed for normal human cathepsin D: (a) it is specifically 
induced  by  estrogens  but  not  progesterone  (Westley  and 
Rochefort, 1980); (b) the secreted 52-kD precursor is mito- 
genic in MCF7 cells (Vignon et al.,  1986); (c) its intracellu- 
lar concentration, as detected by our monoclonal antibodies, 
appears to be much higher in proliferative epithelial mam- 
mary cells and sweat glands than in other tissues, and is low 
in fibroblasts and endometrium (Garcia et al., 1986), where- 
as the distribution of the previously characterized cathepsin 
D  appears more ubiquitous (Barrett,  1977). 
Recently, we compared the Endo H sensitivity of the 52- 
kD-related cellular proteins of MCF7 cells with that of cel- 
lular cathepsin D(s) prepared from several normal tissues 
and found marked differences. After purification using anti- 
bodies to the 52-kD protein, we found that the 34-kD cellular 
cathepsin D from placenta was different from that of breast 
cancer tissue or MCF7 cells in its partial Endo H resistance 
(Fig. 8 A). The three forms in MCF7 cells (52, 48, 34 kD) 
and the 34-kD protein of breast cancer, which is the most 
abundant immunoreactive cellular protein, were totally dis- 
placed by Endo H treatment (Fig. 8 A, lanes a-d), whereas 
in placenta, the 34-kD and a 28-kD protein, probably corre- 
sponding to a proteolytic product, were only partially dis- 
placed by this enzymatic treatment (Fig.  8 A,  lanes e-f). 
Moreover,  authentic  cathepsin  D(s)  prepared  classically 
from human  liver (Barrett,  1970) or from bovine spleen, 
were also both partly resistant to Endo H digestion (Fig.  8 
B). Increasing the concentration of Endo H did not modify 
the proportion (~40%) of Endo H-resistant chains.  These 
results clearly indicate a difference in glycosylation between 
the cathepsin D-like enzymes of human breast cancer and 
those of different normal tissues.  Similar partial resistance 
to Endo H has been described for the human fibroblast ca- 
thepsin D (Hasilik and Von Figura, 1981). One possible con- 
sequence of the complete Endo H  sensitivity of the 52-kD 
cathepsin in breast cancer cells is the high proportion (up to 
50%) of the secretion of its precursor in breast cancer cells 
(Morisset et al., 1986a) compared with normal cells (unpub- 
lished results). This difference suggests a defect in the matu- 
ration of N-glycosylated chains in cancer cells, which may 
be explained at the level of the structure of the protein, or 
at another level, such as enzymes involved in the posttransla- 
tional modifications of this protease. The sequencing of the 
MCF7 52-kD protein from its cloned cDNA and its com- 
parison  with  the  sequence of normal human  cathepsin  D 
(Faust et al.,  1985) will specify the degree of homology be- 
tween these proteases. 
Discussion 
We have shown that the estrogen regulated 52-kD protein 
secreted by human breast cancer cells is the proenzyme of 
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H  sensitivity of cellular  ca- 
thepsin D-like enzymes from 
breast cancers and normal tis- 
sues. (A) A pool of six pri- 
mary  breast  cancers  (HBK) 
and  a  human  placenta  were 
dissected  immediately  after 
surgery or delivery and frozen 
at  -80°C.  Both tissues were 
dipped  into  liquid  nitrogen 
and powdered.  The powders 
were  then  homogenized  at 
0-4°C using an Ultraturrax in 
NP-40 lysis buffer (Capony et 
al.,  1986). The homogenates 
were centrifuged at 100,000 g 
for 30 min and the superna- 
tants were subjected to the pu- 
rification  protocol used for cel- 
lular 52-kD proteins (Capony 
et al.,  1986). Elutions  from 
the 52-kD antibody immuno- 
affinity columns were carried out at pH 11.0. (B) Human liver (lanes a-c) and bovine spleen (lanes d-f) cathepsin D were obtained as 
indicated in Materials and Methods. The purified enzymes (6-10 ~tg/ml) were treated with Endo H as described in Materials and Methods 
using 50 mU/ml (4,) or 200 mU/ml (4-4-) Endo H and an incubation period of 20-24 h at 37°C in the presence of pepstatin. The samples 
were then run on SDS PAGE and revealed by silver staining as in Fig.  1 B. 
a lysosomal acid proteinase similar to cathepsin D. The cel- 
lular processing of the 52-kD protein was separately shown 
using pulse chase experiments (Morisset et al.,  1986a). The 
protein is partly (40%) secreted into the medium and partly 
processed intracellularly into 48- and 34-kD proteins. The 
34-kD  protein  is  more  stable  than  the  other  forms  and 
represents 65 % of the total immunoreactive 52-kD-related 
proteins in cells.  Lysosomotropic agents (NI-hC1,  monen- 
sin) inhibit markedly this intracellular processing in smaller 
proteins. The secretion of precursor of lysosomal hydrolase 
first  described  for I-cell  disease  (Hickman  and  Neufeld, 
1972) has also recently been reported in mouse transformed 
fibroblasts (Gal and Gottesman, 1985). In the human MCF7 
cells, estrogens increase both the synthesis of the cellular 52- 
kD precursor (Morisset et al., 1986a), and to a larger extent, 
its secretion into the medium (Westley and Rochefort, 1980). 
Both the 52-kD precursor and the mature 48- and 34-kD 
proteins are aspartic  proteinases  similar  to the  lysosomal 
cathepsin D on the basis of their molecular mass, inhibitor 
and  substrate  specificities,  and  immunoreactivities.  How- 
ever, there are several differences in the tissue distribution, 
hormonal regulation, glycosylation, and degree of secretion 
when compared with the cathepsin D  from normal tissue. 
These differences as well as the mitogenic activity of the 
protein and its possible action on basement membrane and 
proteoglycans suggest a role of this secreted protein in the 
process of tumor growth and/or invasion. 
Other proteinases have also been reported to be secreted 
specifically from transformed cells. The major excreted pro- 
tein is an activatible acid-proteinase secreted by transformed 
mouse fibroblasts (Gal and Gottesman, 1985). The MEP and 
the 52-kD protein have similar optimal pH activity but are 
clearly different, in that the major excreted protein is a 39-kD 
mouse cysteine proteinase. Another proteinase "transin" se- 
creted by transformed mouse fibroblasts is analogous to a 
collagenase (Matrisian et al.,  1985).  These proteinases may 
have important functions in the process of cancer cell migra- 
tion and metastasis. Another characteristic of the 52-kD ca- 
thepsin D-like proteinase is its autocrine mitogenic activity 
on MCF7 cells (Vignon et al., 1986) by an unknown mecha- 
nism. The 52-kD protein is able to bind plasma membrane 
of MCF7 cells via mannose-6-phosphate receptors but ad- 
ditional  receptors  and/or  its  proteolytic activity  may  be 
required to trigger its mitogenic activity as previously dis- 
cussed for thrombin (Carney and Cunningham,  1978), an- 
other mitogenic proteinase. The autocrine mitogenic activity 
of conditioned  media  prepared  from  estrogen-stimulated 
MCF7 cells (Vignon et al.,  1983) is now confirmed by sev- 
eral groups (Manni et al.,  1986; Dickson et al.,  1986). The 
nature of the estrogen-induced proteins or factors primarily 
responsible for this mitogenic activity in these conditioned 
media is, however, debated. Classical growth factors activat- 
ing transmembrane receptors have been detected by their bi- 
ological and binding activities (Dickson et al.,  1986;  Salo- 
monet al.,  1984).  The estrogen-induced lysosomal 52-kD 
proteinase is another class of autocrine mitogen which may 
be involved in the production of some of these growth factors 
from their inactive precursors. Plasminogen activator is also 
secreted from MCF7 cells and has been reported to be es- 
trogen stimulated  (Butler et al.,  1979; Ryan et al.,  1984). 
This  serine  proteinase  is  also  induced  by  progestins,  its 
amount appears to be less than the 52-kD cathepsin D-like 
enzyme and,  however, it  may act indirectly by activating 
other proteinases such as collagenase (Liotta, 1986).  More- 
over, estradiol also induces serine proteinase inhibitors such 
as the ~tl antichymotrypsin (Massot et al.,  1985). 
In addition to the classical function of cathepsins in intra- 
cellular protein degradation, it has been proposed that these 
proteinases might play a role in the process of tumor invasion 
(Barrett,  1970; Poole,  1979) by helping cancer cells to mi- 
grate,  invade adjacent tissue,  and metastasize.  Our results 
strongly support this hypothesis. Cloning of the cDNA of 
this proteinase is in progress to determine the structure of  the 
protein and its possible function in carcinogenesis. 
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